10737125|t|Lack of association between apolipoprotein E genotype and sporadic amyotrophic lateral sclerosis.
10737125|a|Amyotrophic lateral sclerosis (ALS) is a neuro-degenerative disorder with both sporadic and familial forms. Approximately 20% of autosomal dominant ALS is caused by mutations in the Cu/Zn superoxide dismutase (SOD1) gene. The causes of the remaining forms of ALS are unknown. The apolipoprotein E (APOE) gene is a known genetic risk factor for Alzheimer disease (AD), another neuro-degenerative disease. The APOE-4 allele increases risk and decreases age at onset in AD. Studies examining ALS and APOE have failed to show a significant effect of APOE on overall risk in ALS. Studies examining the effect of APOE-4 on site of onset in ALS (bulbar or limb) have been contradictory, with some studies showing an APOE association with bulbar onset and others showing no effect. Sample size was limited in these previous reports, particularly with respect to the number of bulbar onset cases (n = 33, 34 and 53). The present study examines a large collaborative data set of ALS patients (n = 363; 95 with bulbar onset) and age-matched neurologically normal controls. The results for these data showed no significant differences in the percentage of subjects with the APOE-4/4 and APOE-4/X genotypes (X = APOE-2 or APOE-3) when comparing cases and controls in both the overall data set or in the data set stratified by site of onset. Similarly, logistic regression analysis in the overall and stratified data set while controlling for sex showed no increase or decrease in risk of ALS associated with the APOE-4 allele. In addition, there were no significant differences in age at onset between patients with APOE-X/X, and APOE-4/4 or APOE-4/X genotypes, overall or stratified by site of onset. We conclude based on these data that the APOE gene is not a major genetic risk factor for site of onset in ALS.
10737125	28	44	apolipoprotein E	Gene	348
10737125	67	96	amyotrophic lateral sclerosis	Disease	MESH:D000690
10737125	98	127	Amyotrophic lateral sclerosis	Disease	MESH:D000690
10737125	129	132	ALS	Disease	MESH:D000690
10737125	139	166	neuro-degenerative disorder	Disease	MESH:D019636
10737125	246	249	ALS	Disease	MESH:D000690
10737125	280	306	Cu/Zn superoxide dismutase	Gene	6647
10737125	308	312	SOD1	Gene	6647
10737125	357	360	ALS	Disease	MESH:D000690
10737125	378	394	apolipoprotein E	Gene	348
10737125	396	400	APOE	Gene	348
10737125	442	459	Alzheimer disease	Disease	MESH:D000544
10737125	461	463	AD	Disease	MESH:D000544
10737125	474	500	neuro-degenerative disease	Disease	MESH:D019636
10737125	506	512	APOE-4	Gene	348
10737125	565	567	AD	Disease	MESH:D000544
10737125	587	590	ALS	Disease	MESH:D000690
10737125	595	599	APOE	Gene	348
10737125	644	648	APOE	Gene	348
10737125	668	671	ALS	Disease	MESH:D000690
10737125	705	711	APOE-4	Gene	348
10737125	732	735	ALS	Disease	MESH:D000690
10737125	807	811	APOE	Gene	348
10737125	1067	1070	ALS	Disease	MESH:D000690
10737125	1071	1079	patients	Species	9606
10737125	1260	1268	APOE-4/4	Gene	348
10737125	1273	1279	APOE-4	Gene	348
10737125	1297	1303	APOE-2	Gene	348
10737125	1307	1313	APOE-3	Gene	348
10737125	1573	1576	ALS	Disease	MESH:D000690
10737125	1597	1603	APOE-4	Gene	348
10737125	1687	1695	patients	Species	9606
10737125	1701	1705	APOE	Gene	348
10737125	1715	1723	APOE-4/4	Gene	348
10737125	1727	1733	APOE-4	Gene	348
10737125	1828	1832	APOE	Gene	348
10737125	1894	1897	ALS	Disease	MESH:D000690
10737125	Association	MESH:D000544	348
10737125	Association	MESH:D000690	6647

